Literature DB >> 27502107

A simultaneous assessment metric for MAb quantity and glycan quality.

Gerald Drouillard1, Gordon Hayward2, Julie Vale2, Roshni Dutton2.   

Abstract

As a critical quality attribute, glycosylation represents an important consideration when analyzing the success of a glycoprotein production process. Though critical, glycosylation is not the only measure of culture success; other factors, including culture size, maintenance, and productivity, are also critical. A new metric was developed to address both product quality, as measured through glycosylation, and product quantity, as measured through product concentration. A monoclonal antibody Chinese hamster ovary cell culture model system was used to assess this metric across various media formulations. In a model test system, the metric discriminated that some media supplements had a net positive impact on productivity and glycosylation, while others had a net negative impact on productivity and glycosylation.

Entities:  

Keywords:  Chinese hamster ovary cells (CHO); Critical quality attributes; Glycosylation; Monoclonal antibodies; Productivity

Year:  2016        PMID: 27502107      PMCID: PMC5023566          DOI: 10.1007/s10616-016-0011-1

Source DB:  PubMed          Journal:  Cytotechnology        ISSN: 0920-9069            Impact factor:   2.058


  18 in total

Review 1.  Therapeutic antibodies: market considerations, disease targets and bioprocessing.

Authors:  John G Elvin; Ruairidh G Couston; Christopher F van der Walle
Journal:  Int J Pharm       Date:  2011-12-30       Impact factor: 5.875

2.  Descriptive parameter evaluation in mammalian cell culture.

Authors:  R L Dutton; J M Scharer; M Moo-Young
Journal:  Cytotechnology       Date:  1998-03       Impact factor: 2.058

3.  Anti-inflammatory activity of immunoglobulin G resulting from Fc sialylation.

Authors:  Yoshikatsu Kaneko; Falk Nimmerjahn; Jeffrey V Ravetch
Journal:  Science       Date:  2006-08-04       Impact factor: 47.728

Review 4.  Optimal and consistent protein glycosylation in mammalian cell culture.

Authors:  Patrick Hossler; Sarwat F Khattak; Zheng Jian Li
Journal:  Glycobiology       Date:  2009-06-03       Impact factor: 4.313

5.  Stable expression of chimeric heavy chain antibodies in CHO cells.

Authors:  Vishal Agrawal; Igor Slivac; Sylvie Perret; Louis Bisson; Gilles St-Laurent; Yanal Murad; Jianbing Zhang; Yves Durocher
Journal:  Methods Mol Biol       Date:  2012

6.  Modulation of antibody galactosylation through feeding of uridine, manganese chloride, and galactose.

Authors:  Michael J Gramer; Jackie J Eckblad; Ruth Donahue; Joseph Brown; Carrie Shultz; Kent Vickerman; Patrick Priem; Ewald T J van den Bremer; Jolanda Gerritsen; Patrick H C van Berkel
Journal:  Biotechnol Bioeng       Date:  2011-02-18       Impact factor: 4.530

7.  The availability of glucose to CHO cells affects the intracellular lipid-linked oligosaccharide distribution, site occupancy and the N-glycosylation profile of a monoclonal antibody.

Authors:  Bo Liu; Maureen Spearman; John Doering; Erica Lattová; Hélène Perreault; Michael Butler
Journal:  J Biotechnol       Date:  2013-11-25       Impact factor: 3.307

8.  Detailed structural analysis of N-glycans released from glycoproteins in SDS-PAGE gel bands using HPLC combined with exoglycosidase array digestions.

Authors:  Louise Royle; Catherine M Radcliffe; Raymond A Dwek; Pauline M Rudd
Journal:  Methods Mol Biol       Date:  2006

9.  Differential tumor-targeting abilities of three single-domain antibody formats.

Authors:  Andrea Bell; Zheng J Wang; Mehdi Arbabi-Ghahroudi; Tingtung A Chang; Yves Durocher; Ulrike Trojahn; Jason Baardsnes; Maria L Jaramillo; Shenghua Li; Toya N Baral; Maureen O'Connor-McCourt; Roger Mackenzie; Jianbing Zhang
Journal:  Cancer Lett       Date:  2009-08-28       Impact factor: 8.679

10.  Developement of serum-free media in CHO-DG44 cells using a central composite statistical design.

Authors:  Ananth Parampalli; Kent Eskridge; Leonard Smith; Michael M Meagher; Mark C Mowry; Anuradha Subramanian
Journal:  Cytotechnology       Date:  2007-06-05       Impact factor: 2.058

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.